Javascript must be enabled to continue!
Assessment of Portal Vein Thrombosis in Cirrhotic Liver Patients
View through CrossRef
Background: PVT has a number of frequent causes, including cirrhosis of the liver, abdominal inflammation, tumour invasion, and thrombophilic disorders. Aim: To find out how frequently liver cirrhosis patients get portal vein thrombosis. Study Design: Cross-sectional study, Department of Medicine, Liaquat University Hospital Hyderabad, Sindh, Pakistan's from 1st April 2021 to 30th September 2021.One hundred and twenty eight patients were enrolled. The demographic information like age, sex, and body mass index were noted. Hepatocellular carcinoma patients and history of thromboembolism propensity were excluded. Both male and female patients with hepatic cirrhosis and age ranged from 20 to 50 were included. The monitoring of portal vein thrombosis, Doppler ultrasonography was performed on all patients. Results: There were 40(34.4%) female patients and 84(65.6%) male patients with average age was 51.95 7.54 years and BMI was 31.87 2.64 kg/m2. Seventy nine patients (61.7%) had hepatitis C, 50 patients (39.3%) had hepatitis B, 66 patients (51.6%) had diabetes mellitus, 81 patients (63.3%) had hyperlipidaemia, and 69 patients (57.9%) had hypertension. The prevalence of portal vein thrombosis (PVT) was 81(63.3%), with 48(59.3%) of the cases involving men and 33 (40.7%) involving females. Of them, 25 patients (50%) had hepatitis B and 44 (55.7%) had hepatitis C. Conclusion: Patients with liver cirrhosis experienced portal vein thrombosis often, and hepatitis C patients made up the majority of those afflicted. Keywords: Thrombosis, Portal vein, Liver cirrhosis, thrombophilic disorders
Lahore Medical and Dental College
Title: Assessment of Portal Vein Thrombosis in Cirrhotic Liver Patients
Description:
Background: PVT has a number of frequent causes, including cirrhosis of the liver, abdominal inflammation, tumour invasion, and thrombophilic disorders.
Aim: To find out how frequently liver cirrhosis patients get portal vein thrombosis.
Study Design: Cross-sectional study, Department of Medicine, Liaquat University Hospital Hyderabad, Sindh, Pakistan's from 1st April 2021 to 30th September 2021.
One hundred and twenty eight patients were enrolled.
The demographic information like age, sex, and body mass index were noted.
Hepatocellular carcinoma patients and history of thromboembolism propensity were excluded.
Both male and female patients with hepatic cirrhosis and age ranged from 20 to 50 were included.
The monitoring of portal vein thrombosis, Doppler ultrasonography was performed on all patients.
Results: There were 40(34.
4%) female patients and 84(65.
6%) male patients with average age was 51.
95 7.
54 years and BMI was 31.
87 2.
64 kg/m2.
Seventy nine patients (61.
7%) had hepatitis C, 50 patients (39.
3%) had hepatitis B, 66 patients (51.
6%) had diabetes mellitus, 81 patients (63.
3%) had hyperlipidaemia, and 69 patients (57.
9%) had hypertension.
The prevalence of portal vein thrombosis (PVT) was 81(63.
3%), with 48(59.
3%) of the cases involving men and 33 (40.
7%) involving females.
Of them, 25 patients (50%) had hepatitis B and 44 (55.
7%) had hepatitis C.
Conclusion: Patients with liver cirrhosis experienced portal vein thrombosis often, and hepatitis C patients made up the majority of those afflicted.
Keywords: Thrombosis, Portal vein, Liver cirrhosis, thrombophilic disorders.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?
Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?
Abstract
Abstract 3390
Background:
In the absence of primary liver disease, thrombosis of the splanchnic vessels ...
The Prevalence of JAK2 Mutation in High-Altitude Patients with Unprovoked Thrombosis and Thrombosis at Unusual Sites
The Prevalence of JAK2 Mutation in High-Altitude Patients with Unprovoked Thrombosis and Thrombosis at Unusual Sites
Introduction
Thrombosis, both arterial and venous, is a major source of morbidity and mortality in patients with myeloproliferative neoplasms (MPNs). Thrombosis can ...
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
Background Many cardiovascular conditions exhibit seasonality in occurrence and mortality, but little is known about the seasonality of venous thromboembolism.
Methods ...
Assessment of Bone Mineral Density in Nonalcoholic Steatohepatitis Cirrhosis
Assessment of Bone Mineral Density in Nonalcoholic Steatohepatitis Cirrhosis
Background: Cirrhosis is characterized by diffused hepatic fibrosis and nodule formation that can occur at any age. It has significant morbidity and mortality. Worldwide common cau...
PORTAL VEIN THROMBOSIS – A STUDY OF RISK FACTORS, CLINICAL PROFILE, COMPLICATIONS AND MANAGEMENT
PORTAL VEIN THROMBOSIS – A STUDY OF RISK FACTORS, CLINICAL PROFILE, COMPLICATIONS AND MANAGEMENT
Background: The portal vein is formed by the conuence of the splenic and superior mesenteric veins. Occlusion of the portal vein by thrombus
(portal vein thrombosis [PVT]) typical...
Portal Vein Thrombosis in a Patient with Type 1 Diabetes Presenting as Acute Pyelonephritis
Portal Vein Thrombosis in a Patient with Type 1 Diabetes Presenting as Acute Pyelonephritis
Background: Few cases have been reported with respect to portal vein thrombosis in non-cirrhotic patients. Asymptomatic or non-specific symptoms of portal vein thrombosis may lead ...

